PRIM, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.25 EUR | +2.50% |
|
+2.50% | -1.91% |
| 04-04 | Prim, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-22 | Primoris Services Insider Sold Shares Worth $826,144, According to a Recent SEC Filing | MT |
| Sales 2024 * | 228M 244M 333M | Sales 2025 * | - | Capitalization | 178M 190M 260M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.74 x |
| Net cash position 2024 * | 9.08M 9.71M 13.27M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
9.03
x | P/E ratio 2025 * |
-
| Employees | 900 |
| Yield 2024 * |
5.54% | Yield 2025 * |
-
| Free-Float | 47.28% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.50% | ||
| 1 week | +2.50% | ||
| Current month | +1.99% | ||
| 1 month | +2.50% | ||
| 6 months | -3.30% | ||
| Current year | -1.91% |
1 week
9.96
10.25
1 month
9.5010.60
Current year
9.5010.75
1 year
9.5012.05
3 years
9.5015.75
5 years
8.0015.75
10 years
5.9115.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 20-10-31 | |
| Director of Finance/CFO | - | 17-06-30 | |
| Chairman | - | 19-09-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 15-12-20 | |
| Director/Board Member | - | 18-10-27 | |
| - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 10.25 | +2.50% | 3,803 |
| 24-04-25 | 10 | -1.96% | 5,712 |
| 24-04-24 | 10.2 | 0.00% | 2,215 |
| 24-04-23 | 10.2 | +2.00% | 2,970 |
| 24-04-22 | 10 | 0.00% | 5,537 |
Delayed Quote BME, April 26, 2024 at 11:35 am
More quotes
Prim SA is a Spain-based company principally engaged in the provision of hospital supplies. The Companyâs products portfolio comprises implantable orthopedic products, silicone foot products, abduction splints, mastectomy lingerie, prosthetic components, as well as articulated electric beds and various types of accessories for geriatric centers. Through its subsidiary Inmobiliaria Catharsis SA, the Company is also active in the Real State sector. Prim SA is a parent of Grupo Prim, a group which comprises such a number of controlled entities as Enraf Nonius Iberica SA, Establecimientos Ortopedicos Prim SA, and Luga Suministros Medicos SL, among others.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.25
EUR
Average target price
16.75
EUR
Spread / Average Target
+63.41%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.91% | 190M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +4.01% | 1.13B |
- Stock Market
- Equities
- PRM Stock
